Literature DB >> 24590269

Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer.

Tianbo Liu1, Hongyu Gao, Meng Yang, Tingting Zhao, Yunduo Liu, Ge Lou.   

Abstract

Tumor necrosis factor alpha-induced protein 8 (TNFAIP8) is an apoptosis regulator proven to have an important function in the proliferation, invasion, metastasis, and progression of malignancies. In this study, we investigated the clinical role of TNFAIP8 overexpression in endometrial cancer (EC) and determined the relationship of TNFAIP8 with the proliferative antigen Ki-67 and metastasis-related gene matrix metallopeptidase 9 (MMP9) in 225 tumor specimens by immunohistochemistry and western blot, in order to elucidate more information on the role of TNFAIP8 protein with regard to the pathogenesis of EC. An association was observed between TNFAIP8 overexpression and clinicopathologic factors, such as advanced International Federation of Gynecology and Obstetrics stage (P<0.001), higher histologic grade (P=0.017), deep myometrial invasion (P=0.030), lymphovascular space invasion (P=0.011), lymph node metastasis (P<0.001), and recurrence. Furthermore, TNFAIP8 overexpression was strongly correlated with MMP9 and Ki-67 expression in the progression of ECs. Patients with high expression of TNFAIP8 (P<0.001 for both) and Ki-67 (P=0.007 and P=0.008) had poor overall survival and disease-free survival (DFS) rates. MMP9 overexpression did not affect survival outcomes (P>0.05). Multivariate Cox regression analysis revealed that TNFAIP8 (P=0.029) and lymph node metastasis (P=0.022) were independent factors of DFS in patients with EC. These findings suggested that TNFAIP8 may be used as a prognostic marker for the recurrence of EC, and its promotion of the proliferation and metastasis in EC may be due to its mediation of Ki-67 and MMP9.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24590269     DOI: 10.1007/s13277-014-1770-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

1.  The complexities of proliferating cell nuclear antigen.

Authors:  D McCormick; P A Hall
Journal:  Histopathology       Date:  1992-12       Impact factor: 5.087

2.  A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.

Authors:  B Nordström; P Strang; R Bergström; S Nilsson; B Tribukait
Journal:  Cancer       Date:  1996-11-01       Impact factor: 6.860

3.  The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.

Authors:  Sean Vance; Raphael Yechieli; Chad Cogan; Rabbie Hanna; Adnan Munkarah; Mohamed A Elshaikh
Journal:  Gynecol Oncol       Date:  2012-04-13       Impact factor: 5.482

4.  Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro.

Authors:  D W Park; H S Ryu; D S Choi; Y H Park; K H Chang; C K Min
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

5.  Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels.

Authors:  Ke Liu; Cheng-Kun Qin; Zhi-Yi Wang; Su-Xia Liu; Xian-Ping Cui; Dong-Yuan Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2012

Review 6.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

7.  SCC-S2 is overexpressed in colon cancers and regulates cell proliferation.

Authors:  Zhifeng Miao; Tingting Zhao; Zhenning Wang; Yingying Xu; Yongxi Song; Jianhua Wu; Huimian Xu
Journal:  Tumour Biol       Date:  2012-08-12

8.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

9.  Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.

Authors:  Stefanie M Ueda; Daniel S Kapp; Michael K Cheung; Jacob Y Shin; Kathryn Osann; Amreen Husain; Nelson N Teng; Jonathan S Berek; John K Chan
Journal:  Am J Obstet Gynecol       Date:  2008-02       Impact factor: 8.661

10.  The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin.

Authors:  J R Backstrom; Z A Tökés
Journal:  J Neurochem       Date:  1995-03       Impact factor: 5.372

View more
  29 in total

1.  Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.

Authors:  Likun Li; Styliani Karanika; Guang Yang; Jiangxiang Wang; Sanghee Park; Bradley M Broom; Ganiraju C Manyam; Wenhui Wu; Yong Luo; Spyridon Basourakos; Jian H Song; Gary E Gallick; Theodoros Karantanos; Dimitrios Korentzelos; Abul Kalam Azad; Jeri Kim; Paul G Corn; Ana M Aparicio; Christopher J Logothetis; Patricia Troncoso; Timothy Heffernan; Carlo Toniatti; Hyun-Sung Lee; Ju-Seog Lee; Xuemei Zuo; Wenjun Chang; Jianhua Yin; Timothy C Thompson
Journal:  Sci Signal       Date:  2017-05-23       Impact factor: 8.192

Review 2.  Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins.

Authors:  Jason R Goldsmith; Svetlana Fayngerts; Youhai H Chen
Journal:  Cell Mol Immunol       Date:  2017-03-13       Impact factor: 11.530

3.  Genome-wide analysis of androgen receptor binding sites in prostate cancer cells.

Authors:  Yue Cheng; Pan Yu; Xiuzhi Duan; Chunhua Liu; Siqi Xu; Yuhua Chen; Yunnian Tan; Yun Qiang; Junfang Shen; Zhihua Tao
Journal:  Exp Ther Med       Date:  2015-04-03       Impact factor: 2.447

4.  Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma.

Authors:  Yichong Wang; Jiufeng Wei; Shujun Zhang; Guodong Li; Tao Zhang; Xin Yu; Hongsheng Chen; Ming Liu
Journal:  Tumour Biol       Date:  2015-06-09

5.  The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression.

Authors:  Julie M Lowe; Thuy-Ai Nguyen; Sara A Grimm; Kristin A Gabor; Shyamal D Peddada; Leping Li; Carl W Anderson; Michael A Resnick; Daniel Menendez; Michael B Fessler
Journal:  Cell Death Differ       Date:  2016-11-11       Impact factor: 15.828

6.  MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8.

Authors:  Hong-Yu Gao; Fu-Chun Huo; Hai-Yan Wang; Dong-Sheng Pei
Journal:  Cell Prolif       Date:  2017-01-27       Impact factor: 6.831

7.  Immunohistochemical Study of Ki-67 in Hyperplastic and Endometrium Carcinoma: A Comparative Study.

Authors:  R Ghalib Farhood; I Abd Ali Al-Humairi
Journal:  Arch Razi Inst       Date:  2022-02-28

8.  TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.

Authors:  Zhenguo Sun; Xiangyan Liu; Jee Hoon Song; Yulan Cheng; Yu Liu; Yang Jia; Stephen J Meltzer; Zhou Wang
Journal:  Tumour Biol       Date:  2016-02-17

9.  Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Tahereh Farkhondeh; Alireza Amirabadizadeh; Hamed Aramjoo; Silvia Llorens; Babak Roshanravan; Farhad Saeedi; Marjan Talebi; Mehdi Shakibaei; Saeed Samarghandian
Journal:  Curr Oncol       Date:  2021-04-06       Impact factor: 3.677

10.  In Silico Analysis of Tumor Necrosis Factor α-Induced Protein 8-Like-1 (TIPE1) Protein.

Authors:  Pei Shen; Hong Zhang; Zhaoliang Su; Shengjun Wang; Huaxi Xu
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.